81 Recruiting Anatomic Stage III Breast Cancer AJCC v8 Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Anatomic Stage III Breast Cancer AJCC v8
Related Conditions
Top Recruiting Anatomic Stage III Breast Cancer AJCC v8 Studies
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
📍 UF Health Cancer Institute - Gainesville — Gainesville, Florida
View Study & Checklist ➔Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
View Study & Checklist ➔Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔SHAPE Neoadjuvant Chemotherapy Response
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
📍 Keck Medicine of USC Koreatown — Los Angeles, California
View Study & Checklist ➔Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
📍 Siteman Cancer Center at Washington University — St Louis, Missouri
View Study & Checklist ➔Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
📍 Mayo Clinic in Florida — Jacksonville, Florida
View Study & Checklist ➔Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
📍 Boston Medical Center — Boston, Massachusetts
View Study & Checklist ➔Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
📍 Emory University Hospital — Atlanta, Georgia
View Study & Checklist ➔Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔